PPARγ调控脂滴相关蛋白caveolin-2影响口腔上皮异常增生的作用及机制研究
批准号:
82101023
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
陈潇婕
依托单位:
学科分类:
牙周及口腔黏膜疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
陈潇婕
中文摘要
口腔潜在恶性疾病(OPMDs)具有发生上皮异常增生的潜能,明确上皮异常增生的调控机制对预防口腔癌具有重大意义。脂滴作为脂质中心在细胞上皮-间充质转化(EMT)中起着重要作用。基于申请人的前期研究结果及文献总结,本课题的假说为过氧化物酶体增殖物激活受体γ(PPARγ)通过调控与脂滴功能相关的窖蛋白-2(caveolin-2),影响脂肪酸由脂滴向线粒体运输、氧化,调控口腔上皮细胞异常增生。为验证该假说,本项目以脂滴为切入点,验证脂滴相关分子表达及其与口腔上皮异常增生的关系,明确其临床意义;探索PPARγ通过调控caveolin-2干预脂滴向线粒体输送脂肪酸的机制及对口腔上皮异常增生的影响;构建人工脂滴,评估其作为纳米载体治疗OPMDs的稳定性、有效性及安全性。本课题不仅有助于阐明脂滴调控的脂代谢重塑与口腔上皮异常增生的关系,明确相关分子机制,还可为OPMDs的防治提供重要思路与依据。
英文摘要
Oral potentially malignant disorders (OPMDs) have the risk of epithelial dysplasia. It is of great significance to clarify the regulatory mechanism of epithelial dysplasia for the prevention of oral cancer. Lipid droplets, as lipid center, play an important role in epithelial to mesenchymal transition (EMT). Based on our previous research and literature review on OPMDs, the hypothesis of this project is that peroxisome proliferator activated receptor gamma (PPARγ) affects the transport of fatty acid to mitochondria and fatty acid oxidation by regulating caveolin-2 expression, which is related to lipid droplet function, and thus regulates the oral epithelial dysplasia. In order to verify this hypothesis, this research takes lipid droplets as the breakthrough point to verify the expression of lipid droplet related molecules and its relationship with oral epithelial dysplasia, and clarify its clinical significance; explore the mechanism of PPARγ intervening lipid droplets to transport fatty acids to mitochondria by regulating caveolin-2; clarify the effect of lipid droplets' functional changes on fatty acid β-oxidation and oral epithelial dysplasia; construct artificial lipid droplets, and evaluate its stability, efficacy and safety as nano carriers for the treatment of oral epithelial dysplasia. This research not only helps to clarify the molecular mechanism and the relationship between oral epithelial dysplasia and lipid metabolism remodeling regulated by lipid droplets, but also provides new strategies and basis for the prevention and treatment of OPMDs.
脂代谢在可能在口腔癌变过程中发挥重要作用,本项目旨在探索脂滴(LDs)功能分子caveolin-2(CAV2)的在口腔上皮异常增生中的作用及机制。.首先,通过HE和油红O染色检测正常口腔上皮、口腔白斑(OLK)和口腔鳞状细胞癌(OSCC)组织中脂滴及EMT相关分子的表达。进一步,采用shRNA下调OSCC细胞中CAV2,以评估其对细胞生长、凋亡、迁移和侵袭以及脂滴动力学和功能的影响。然后,进行非靶向脂质组学分析,并检测线粒体功能和凋亡相关蛋白表达。使用相关性分析研究PPARγ和CAV2之间的关系,并通过生物信息学分析、双荧光素酶报告、共免疫沉淀等技术进行分析验证。用PPARγ反向激动剂T0070907增强CAV2沉默,并评估其对细胞生长、凋亡、脂解和线粒体功能的影响。构建裸鼠荷瘤模型及4NQO诱导的小鼠口腔癌变模型,体内验证CAV2相关机制。.组织学研究发现,LDs在OLK早期就开始积累,CAV2可能是主要功能蛋白,可能参与脂质代谢调节,并与EMT过程密切相关。体内研究发现,敲减CAV2可增加OSCC细胞凋亡,减少细胞增殖、迁移和侵袭。CAV2可靶向LDs,影响其动力学并在敲减后启动脂肪分解。CAV2沉默可导致脂肪分解和PUFA生物合成增强,升高二酰基甘油和多不饱和脂肪酸水平。敲减CAV2导致线粒体功能受损,并通过BCL2/JUN信号通诱导线粒体凋亡。PPARγ抑制了CAV2的转录活性,NCOR1的异常募集可导致CAV2失调。使用PPARγ反向激动剂T0070907增强PPARγ/NCOR1转录抑制复合物的形成,可增强CAV2抑制,将其与CAV2敲减联合使用,可导致OSCC细胞中脂肪分解、线粒体功能障碍和凋亡。在裸鼠荷瘤模型和4NQO诱导的小鼠口腔癌变模型中,CAV2敲除可以通过干扰脂代谢抑制口腔上皮异常增生。综上,PPARγ/CAV2是口腔黏膜癌变的关键代谢轴,是潜在的新治疗靶点。
国内基金
海外基金